My Cart [ 0 ]
Proteins & Peptides
New Products
New Services
Promotions
News
Home > Proteins & Peptides
Natural and recombinant proteins purified from bacteria (such as E. coli, B. subtilis), yeast (such as S. cerevisiae), baculovirus/insect, mammalian cells (such as CHO cell lines), and cell-free systems.
    6311 Proteins & Peptides Products
  • BP000137-CYT-230: Recombinant Human Interleukin-15 (IL-15) Protein

    Source: E. coli-derived.
    The ED50 as determined by the dose-dependant stimulation of the proliferation of mouse CTLL-2 was found to be < 0.5 ug/ml, corresponding to a Specific Activity of 2 MIU/mg.
    Purity: > 98% by SDS-PAGE and RP-HPLC.

  • BP000136-CYT-375: Recombinant Mouse IL-13

    Source: E. coli-derived.
    A single, non-glycosylated polypeptide chain containing 110 amino acids and having a molecular mass of 12 kDa.
    The ED50 range=2-6 ug/ml corresponding to a specific activity of 0.17-0.5 MU/mg, determined by the dose dependent prolifiration of TF-1 cells.
    Purity > 95%, by SDS-PAGE.

  • BP000136-CYT-446: Recombinant Human IL-13

    Source: E. coli-derived.
    The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of 1 MIU/mg.
    Purity > 95%, by SDS-PAGE and RP-HPLC.

  • BP000136-CYT-489: Recombinant Human IL-13, His Tag

    Source: E. coli-derived.
    Purity > 95%, by SDS--PAGE and RP-HPLC.

  • BP000136-CYT-682: Recombinant Human IL-13 Variant

    Source: E. coli-derived.
    The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of >1,000,000 units/mg. This analog has also been shown to exhibit increased in vivo activity compared to wild type IL-13.
    Purity > 95%, by SDS--PAGE and RP-HPLC.

  • BP000136-CYT-391: Recombinant Rat IL-13

    Source: E. coli-derived.
    Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
    Purity > 95%, by SDS-PAGE.

  • BP000133-CYT-497: Recombinant Mouse Interleukin-10 (IL-10) Protein

    Source: E. coli-derived.
    The ED50 as determined by the dose-dependant co-stimulation with IL-4 of mouse MC-9 cells was found to be < 2 ug/ml, corresponding to a Specific Activity of 500,000 IU/mg.
    Purity: > 98% by SDS-PAGE and RP-HPLC.

  • BP000135-CYT-488: Recombinant Human IL-12 p40

    Source: E. coli-derived.
    Purity > 95%, by SDS-PAGE and RP-HPLC.

  • BP000135-CYT-390: Recombinant Rat IL-12

    Source: E. coli-derived.
    ED50 range = 0.01-0.05 ug/ml corresponding to a specific activity of 20-100 MIU/mg as determined by the dose dependent secretion of interferon-gamma from PHA and IL-2 activated mouse splenocytes that have been costimulated with PMA. Optimal concentration for individual application should be determined by a dose response assay.
    Purity > 95%, by SDS-PAGE and RP-HPLC.

  • BP000135-CYT-362: Recombinant Human IL-12

    Source: E. coli-derived.
    It is recommended to reconstitute the lyophilized Interleukin-12 in sterile 18 M?-cm H2O not less than 100 ug/ml, which can then be further diluted to other aqueous solutions.
    Purity > 98%, by SDS-PAGE and RP-HPLC.

Proteins & Peptides Categories

See our Privacy Policy